A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2019
Price : $35 *
At a glance
- Drugs Streptococcal B vaccine conjugate (Primary)
- Indications Streptococcal infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; Novartis Vaccines
- 30 Mar 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 09 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Apr 2016 as reported by ClinicalTrial.gov record.
- 09 Nov 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Feb 2016 as reported by ClinicalTrial.gov record.